{"DataElement":{"publicId":"5156241","version":"1","preferredName":"Chimeric Antigen Receptor Use Type","preferredDefinition":"A description of the chimeric antigen receptor used.","longName":"5156257v1.0:5156209v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5156257","version":"1","preferredName":"Chimeric Antigen Receptor Use","preferredDefinition":"A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell._A manner, or usual, or accepted practice of using something.","longName":"5233611v1.0:2234899v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5233611","version":"1","preferredName":"Chimeric Antigen Receptor","preferredDefinition":"A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.","longName":"C126108","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chimeric Antigen Receptor","conceptCode":"C126108","definition":"A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31551FC3-6C6B-0FE3-E050-BB89AD43041C","latestVersionIndicator":"Yes","beginDate":"2016-04-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-04-25","modifiedBy":"ONEDATA","dateModified":"2016-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234899","version":"1","preferredName":"Use","preferredDefinition":"Use; put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.","longName":"C25340","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Use","conceptCode":"C25340","definition":"A manner, or usual, or accepted practice of using something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-7486-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-15","modifiedBy":"ONEDATA","dateModified":"2005-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2861582","version":"1","preferredName":"Role","preferredDefinition":"The values that are permitted for the usual or expected function of something; the part something plays in an action or event. [Source: NCI]","longName":"ROLE","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67F34359-7D35-ED41-E040-BB89AD437390","latestVersionIndicator":"Yes","beginDate":"2009-04-19","endDate":null,"createdBy":"DWARZEL","dateCreated":"2009-04-19","modifiedBy":"DWARZEL","dateModified":"2009-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E19C753-A720-5133-E050-BB89AD433957","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"NYCHM","dateModified":"2016-07-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5156209","version":"1","preferredName":"Chimeric Antigen Receptor Type","preferredDefinition":"A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell._Something distinguishable as an identifiable class based on common qualities.","longName":"5156209v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"OX40","valueDescription":"Tumor Necrosis Factor Receptor Superfamily Member 4","ValueMeaning":{"publicId":"5156216","version":"1","preferredName":"Tumor Necrosis Factor Receptor Superfamily Member 4","longName":"5156216","preferredDefinition":"Tumor necrosis factor receptor superfamily member 4 (277 aa, ~29 kDa) is encoded by the human TNFRSF4 gene. This protein plays a role in signal transduction pathways that mediate apoptosis inhibition and inflammatory responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Necrosis Factor Receptor Superfamily Member 4","conceptCode":"C94790","definition":"Tumor necrosis factor receptor superfamily member 4 (277 aa, ~29 kDa) is encoded by the human TNFRSF4 gene. This protein plays a role in signal transduction pathways that mediate apoptosis inhibition and inflammatory responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E19987B-427C-0FE9-E050-BB89AD435F86","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E19987B-4295-0FE9-E050-BB89AD435F86","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"ONEDATA","dateModified":"2016-03-15","deletedIndicator":"No"},{"value":"ICOS","valueDescription":"ICOS Gene Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3541556","version":"1","preferredName":"ICOS Gene Immunodeficiency Syndrome","longName":"3541556","preferredDefinition":"This gene is involved in the immune response.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ICOS Gene","conceptCode":"C94801","definition":"This gene is involved in the immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C661F4F8-E1C0-BB1A-E040-BB89AD436C64","latestVersionIndicator":"Yes","beginDate":"2012-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-03","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E19987B-429F-0FE9-E050-BB89AD435F86","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"ONEDATA","dateModified":"2016-03-15","deletedIndicator":"No"},{"value":"CD28","valueDescription":"T-Cell Specific Surface Glycoprotein CD28","ValueMeaning":{"publicId":"5156218","version":"1","preferredName":"T-Cell Specific Surface Glycoprotein CD28","longName":"5156218","preferredDefinition":"T-Cell specific surface glycoprotein CD28 (220 aa, 25 kD) is a cell fate protein that is encoded by the human CD28 gene and has roles in regulation of apoptosis and humoral immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell-Specific Surface Glycoprotein CD28","conceptCode":"C17336","definition":"T-cell-specific surface glycoprotein CD28 (220 aa, ~25 kDa) is encoded by the human CD28 gene. This protein is involved in the survival and activation of T-lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E19987B-42AC-0FE9-E050-BB89AD435F86","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E19987B-42C5-0FE9-E050-BB89AD435F86","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"ONEDATA","dateModified":"2016-03-15","deletedIndicator":"No"},{"value":"CD27","valueDescription":"CD27 Gene","ValueMeaning":{"publicId":"5156220","version":"1","preferredName":"CD27 Gene","longName":"5156220","preferredDefinition":"This gene is involved in maintenance of T cell immunity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD27 Gene","conceptCode":"C104071","definition":"This gene is involved in maintenance of T cell immunity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E19987B-42D2-0FE9-E050-BB89AD435F86","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E19987B-42EB-0FE9-E050-BB89AD435F86","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"ONEDATA","dateModified":"2016-03-15","deletedIndicator":"No"},{"value":"EGFR","valueDescription":"EGFR Gene","ValueMeaning":{"publicId":"5156222","version":"1","preferredName":"EGFR Gene","longName":"5156222","preferredDefinition":"This gene is involved in the epidermal growth factor signal transduction pathway.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR Gene","conceptCode":"C17757","definition":"This gene is involved in the epidermal growth factor signal transduction pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E19C753-A5DF-5133-E050-BB89AD433957","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E19C753-A5F8-5133-E050-BB89AD433957","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"ONEDATA","dateModified":"2016-03-15","deletedIndicator":"No"},{"value":"4-1BB","valueDescription":"Tumor Necrosis Factor Receptor Superfamily Member 9","ValueMeaning":{"publicId":"5156224","version":"1","preferredName":"Tumor Necrosis Factor Receptor Superfamily Member 9","longName":"5156224","preferredDefinition":"Tumor necrosis factor receptor superfamily member 9 (255 aa, ~28 kDa) is encoded by the human TNFRSF9 gene. This protein plays a role in receptor signal transduction in activated T-lymphocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Necrosis Factor Receptor Superfamily Member 9","conceptCode":"C105113","definition":"Tumor necrosis factor receptor superfamily member 9 (255 aa, ~28 kDa) is encoded by the human TNFRSF9 gene. This protein plays a role in receptor signal transduction in activated T-lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E19C753-A605-5133-E050-BB89AD433957","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E19C753-A61E-5133-E050-BB89AD433957","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"ONEDATA","dateModified":"2016-03-15","deletedIndicator":"No"},{"value":"CD3/ZETA/","valueDescription":"T-Cell Surface Glycoprotein CD3 Zeta Chain Immunodeficiency Syndrome","ValueMeaning":{"publicId":"5156210","version":"1","preferredName":"T-Cell Surface Glycoprotein CD3 Zeta Chain Immunodeficiency Syndrome","longName":"5156210","preferredDefinition":"T-cell surface glycoprotein CD3 zeta chain (164 aa, ~18 kDa) is encoded by the human CD247 gene. This protein is involved in T-cell intracellular signaling.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD3 Zeta Chain","conceptCode":"C38903","definition":"T-cell surface glycoprotein CD3 zeta chain (164 aa, ~18 kDa) is encoded by the human CD247 gene. This protein is involved in T-cell intracellular signaling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E19987B-4254-0FE9-E050-BB89AD435F86","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3812E8C8-1474-2058-E050-BB89AD433EA5","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-07-20","modifiedBy":"ONEDATA","dateModified":"2016-07-20","deletedIndicator":"No"},{"value":"Other construct","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"315561CE-049D-A2C8-E050-BB89AD436FD9","beginDate":"2016-04-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-04-25","modifiedBy":"ONEDATA","dateModified":"2016-04-25","deletedIndicator":"No"},{"value":"MUC16","valueDescription":"MUC16 Gene","ValueMeaning":{"publicId":"3684765","version":"1","preferredName":"MUC16 Gene","longName":"3684765","preferredDefinition":"This gene is involved in both cellular adhesion and the maintenance of mucosal surfaces.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MUC16 Gene","conceptCode":"C71018","definition":"This gene is involved in both cellular adhesion and the maintenance of mucosal surfaces.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5886F79-026C-473B-E040-BB89AD4308CF","latestVersionIndicator":"Yes","beginDate":"2013-02-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-02-12","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1EBE88-3D73-2E29-E053-F662850AA907","beginDate":"2017-11-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-11-16","modifiedBy":"ONEDATA","dateModified":"2017-11-16","deletedIndicator":"No"},{"value":"Tandem","valueDescription":"Tandem Chimeric Antigen Receptor","ValueMeaning":{"publicId":"7487197","version":"1","preferredName":"Tandem Chimeric Antigen Receptor","longName":"7487197","preferredDefinition":"A chimeric antigen receptor engineered to with two antigen domains linked consecutively, designed to target two distinct tumor antigens.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tandem Chimeric Antigen Receptor","conceptCode":"C175586","definition":"A chimeric antigen receptor engineered to with two antigen domains linked consecutively, designed to target two distinct tumor antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3150639-B20E-6F00-E053-4EBD850ABA4E","latestVersionIndicator":"Yes","beginDate":"2020-11-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-02","modifiedBy":"ONEDATA","dateModified":"2020-11-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3150639-B227-6F00-E053-4EBD850ABA4E","beginDate":"2020-11-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-02","modifiedBy":"ONEDATA","dateModified":"2020-11-02","deletedIndicator":"No"},{"value":"Bicistronic","valueDescription":"Bicistronic Chimeric Antigen Receptor Vector","ValueMeaning":{"publicId":"7487198","version":"1","preferredName":"Bicistronic Chimeric Antigen Receptor Vector","longName":"7487198","preferredDefinition":"A genetic vector (plasmid, viral vector or artificial chromosome) that is engineered to express two distinct chimeric antigen receptor proteins. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bicistronic Chimeric Antigen Receptor Vector","conceptCode":"C175587","definition":"A genetic vector (plasmid, viral vector or artificial chromosome) that is engineered to express two distinct chimeric antigen receptor proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3150639-B233-6F00-E053-4EBD850ABA4E","latestVersionIndicator":"Yes","beginDate":"2020-11-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-02","modifiedBy":"ONEDATA","dateModified":"2020-11-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3150639-B24C-6F00-E053-4EBD850ABA4E","beginDate":"2020-11-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-02","modifiedBy":"ONEDATA","dateModified":"2020-11-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435032","version":"1","preferredName":"Property or Attribute","preferredDefinition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C20189","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8321-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5156242","version":"1","preferredName":"Chimeric Antigen Receptor Construct Type","preferredDefinition":"A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.:An abstract or general idea inferred or derived from specific instances.:Something distinguishable as an identifiable class based on common qualities.","longName":"C126108:C84378:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chimeric Antigen Receptor","conceptCode":"C126108","definition":"A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Construct","conceptCode":"C84378","definition":"An abstract or general idea inferred or derived from specific instances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E19C753-A668-5133-E050-BB89AD433957","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"ONEDATA","dateModified":"2016-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E19987B-423E-0FE9-E050-BB89AD435F86","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":".Added PV for 4003. AK11/16/17 2020-11-2 ak Added 2 PVs for KM.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685478","version":"1","longName":"Testing Set – Moderately Different","context":"NCIP"}]}],"AlternateNames":[{"name":"CTI_CPMM_car_use_ty","type":"NMDP_FN","context":"NHLBI"},{"name":"Biologic:typeCode","type":"HCT_BRIDG_5","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the chimeric antigen","type":"Preferred Question Text","description":"What was the chimeric antigen receptor that was used?","url":null,"context":"NHLBI"},{"name":"Specify details of the CAR construct","type":"Alternate Question Text","description":"Specify details of the CAR construct","url":null,"context":"NHLBI"},{"name":"Specify details of the CAR construct","type":"Application Standard Question Text","description":"Specify details of the CAR construct","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E19C753-A628-5133-E050-BB89AD433957","latestVersionIndicator":"Yes","beginDate":"2016-03-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-15","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":"Added HCT_BRIDG5 alternate name - RR 2018-12-23","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}